Received Apr 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | PC5Y3 | — |
vaccine was not reconstitied with the adjuvant was just administered; vaccine was not reconstitied with the adjuvant was just administered; This non-serious case was reported by a nurse via sales rep and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) (batch number PC5Y3, expiry date 30-JAN-2027) for prophylaxis. In APR-2025, the patient received Shingrix (unknown deltoid). In APR-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: vaccine was not reconstitied with the adjuvant was just administered) and inappropriate dose of vaccine administered (Verbatim: vaccine was not reconstitied with the adjuvant was just administered). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 14-APR-2025 There were no symptoms had been reported. Only adjuvant was administered to the patient without having it mixed with the Vaccine Inappropriate dose of vaccine administered and Inappropriate preparation of medication. The health care professional was unaware to whom they administered it too. It was when they were checking on their product quantity, they found out that the vaccine was not reconstituted with the adjuvant and the adjuvant was just administered. Unsure about primary disease because they do not know the patient and usually patient take it as a preventive measures. No further information.